Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Gram-Positive Bacteria - Mycobacterium tuberculosis is the subject of a report. According to news orig inating from Oxford, United Kingdom, by NewsRx correspondents, research stated, "Pyrazinamide is one of four first-line antibiotics used to treat tuberculosis; however, antibiotic susceptibility testing for pyrazinamide is challenging. Resi stance to pyrazinamide is primarily driven by genetic variation in , encoding an enzyme that converts pyrazinamide into its active form." Financial supporters for this research include National Institute for Health Res earch Health Protection Research Unit, Public Health England, National Institute for Health Research, Oxford Biomedical Research Centre, Wellcome Trust, Newton Fund-MRC, Bill and Melinda Gates Foundation, European Commission, South African Medical Research Council, National Institutes of Health, Rhodes Trust, EPSRC, NI HR Senior Investigators, NIHR Academic Clinical Lecturer, TORCH, Flemish Fund fo r Scientific Research, Claude Leon Foundation, NHS, Department of Health, Center s for Disease Control and Prevention, US Department of Health and Human Services .
NETL
NSTL